| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 4 | -626K | 100% | $60.48 | -$37.9M |
| Net | -4 | -626K | -100% | -$37.9M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Chandler Robinson | Chief Executive Officer, Director | $22.9M | -$672K | -2.85% | Dec 2, 2025 |
| Tactic Pharma LLC | 10%+ Owner | $17.3M | -$36.2M | -67.6% | Sep 24, 2025 |
| Andrew Cittadine | Chief Operating Officer | $5.08M | Dec 2, 2025 | ||
| Christopher M. Starr | Director | $539K | -$672K | -55.5% | Dec 2, 2025 |
| Kim R. Tsuchimoto | Director | $459K | -$356K | -43.7% | Dec 2, 2025 |
| Lavina Talukdar | Director | $308K | Dec 2, 2025 | ||
| Michael J. Brown | Director | $137K | Dec 31, 2023 | ||
| Andrew Paul Mazar | Chief Scientific Officer, Director | $94.4K | Mar 31, 2022 | ||
| Karthik Radhakrishnan | Chief Financial Officer | $10.4K | Oct 28, 2024 | ||
| TacticGem LLC | 10%+ Owner | $0 | Dec 9, 2024 | ||
| Jose Octavio Filho | Chief Medical Officer | Jul 12, 2021 | |||
| Patrice Rioux | Acting Chief Medical Officer | Jan 1, 2025 | |||
| Arthur J. Klausner | Director | Dec 2, 2025 | |||
| Raymond Anderson | Director | Dec 2, 2025 | |||
| Quan Vu | Chief Financial Officer | Dec 2, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|